Proton spectroscopy in asymptomatic HIV-infected adults: Initial results in a prospective cohort study

Jeffrey G. Jarvik, Robert E. Lenkinski, Andrew Saykin, Anna Jaans, Ian Frank

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The purpose of our study was to determine whether proton magnetic resonance spectroscopy (MRS) could detect early brain involvement by human immunodeficiency virus (HIV). We recruited 19 asymptomatic HIV-infected patients, 9 with and 10 without a history of intravenous drug use (IDU), as well as 10 control subjects. All subjects had to have normal MR imaging to be enrolled. We identified the following peaks on proton MRS: n-acetyl aspartate, creatine, choline, and a conglomerate amino acid peak between 2.1 and 2.6 parts per million that we call the marker peaks. Proton MRS was able to demonstrate a statistically significant difference between HIV-infected subjects and controls. The marker/Cr was the best ratio to separate patients from controls, with controls having a mean ratio of 0.50 ± 0.51 and patients having a mean ratio of 1.8 ± 0.85 (p = 0.001). There was no difference between HIV-infected subjects with and without a history of IDU. No significant relationship was found between either neuropsychological test scores or CD4 count and metabolite ratios. In brief, MRS seems more sensitive than magnetic resonance imaging (MRI), being able to detect abnormalities in HIV-infected patients when imaging is normal.

Original languageEnglish (US)
Pages (from-to)247-253
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Volume13
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

Protons
Spectrum Analysis
Cohort Studies
HIV
Prospective Studies
Creatine
Neuropsychological Tests
CD4 Lymphocyte Count
Choline
Aspartic Acid
Pharmaceutical Preparations
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Amino Acids
Brain
Proton Magnetic Resonance Spectroscopy

Keywords

  • HIV
  • Magnetic resonance spectroscopy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Virology

Cite this

Proton spectroscopy in asymptomatic HIV-infected adults : Initial results in a prospective cohort study. / Jarvik, Jeffrey G.; Lenkinski, Robert E.; Saykin, Andrew; Jaans, Anna; Frank, Ian.

In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 13, No. 3, 1996, p. 247-253.

Research output: Contribution to journalArticle

@article{5938e29770534b99b2a9f1a08098c55a,
title = "Proton spectroscopy in asymptomatic HIV-infected adults: Initial results in a prospective cohort study",
abstract = "The purpose of our study was to determine whether proton magnetic resonance spectroscopy (MRS) could detect early brain involvement by human immunodeficiency virus (HIV). We recruited 19 asymptomatic HIV-infected patients, 9 with and 10 without a history of intravenous drug use (IDU), as well as 10 control subjects. All subjects had to have normal MR imaging to be enrolled. We identified the following peaks on proton MRS: n-acetyl aspartate, creatine, choline, and a conglomerate amino acid peak between 2.1 and 2.6 parts per million that we call the marker peaks. Proton MRS was able to demonstrate a statistically significant difference between HIV-infected subjects and controls. The marker/Cr was the best ratio to separate patients from controls, with controls having a mean ratio of 0.50 ± 0.51 and patients having a mean ratio of 1.8 ± 0.85 (p = 0.001). There was no difference between HIV-infected subjects with and without a history of IDU. No significant relationship was found between either neuropsychological test scores or CD4 count and metabolite ratios. In brief, MRS seems more sensitive than magnetic resonance imaging (MRI), being able to detect abnormalities in HIV-infected patients when imaging is normal.",
keywords = "HIV, Magnetic resonance spectroscopy",
author = "Jarvik, {Jeffrey G.} and Lenkinski, {Robert E.} and Andrew Saykin and Anna Jaans and Ian Frank",
year = "1996",
language = "English (US)",
volume = "13",
pages = "247--253",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Proton spectroscopy in asymptomatic HIV-infected adults

T2 - Initial results in a prospective cohort study

AU - Jarvik, Jeffrey G.

AU - Lenkinski, Robert E.

AU - Saykin, Andrew

AU - Jaans, Anna

AU - Frank, Ian

PY - 1996

Y1 - 1996

N2 - The purpose of our study was to determine whether proton magnetic resonance spectroscopy (MRS) could detect early brain involvement by human immunodeficiency virus (HIV). We recruited 19 asymptomatic HIV-infected patients, 9 with and 10 without a history of intravenous drug use (IDU), as well as 10 control subjects. All subjects had to have normal MR imaging to be enrolled. We identified the following peaks on proton MRS: n-acetyl aspartate, creatine, choline, and a conglomerate amino acid peak between 2.1 and 2.6 parts per million that we call the marker peaks. Proton MRS was able to demonstrate a statistically significant difference between HIV-infected subjects and controls. The marker/Cr was the best ratio to separate patients from controls, with controls having a mean ratio of 0.50 ± 0.51 and patients having a mean ratio of 1.8 ± 0.85 (p = 0.001). There was no difference between HIV-infected subjects with and without a history of IDU. No significant relationship was found between either neuropsychological test scores or CD4 count and metabolite ratios. In brief, MRS seems more sensitive than magnetic resonance imaging (MRI), being able to detect abnormalities in HIV-infected patients when imaging is normal.

AB - The purpose of our study was to determine whether proton magnetic resonance spectroscopy (MRS) could detect early brain involvement by human immunodeficiency virus (HIV). We recruited 19 asymptomatic HIV-infected patients, 9 with and 10 without a history of intravenous drug use (IDU), as well as 10 control subjects. All subjects had to have normal MR imaging to be enrolled. We identified the following peaks on proton MRS: n-acetyl aspartate, creatine, choline, and a conglomerate amino acid peak between 2.1 and 2.6 parts per million that we call the marker peaks. Proton MRS was able to demonstrate a statistically significant difference between HIV-infected subjects and controls. The marker/Cr was the best ratio to separate patients from controls, with controls having a mean ratio of 0.50 ± 0.51 and patients having a mean ratio of 1.8 ± 0.85 (p = 0.001). There was no difference between HIV-infected subjects with and without a history of IDU. No significant relationship was found between either neuropsychological test scores or CD4 count and metabolite ratios. In brief, MRS seems more sensitive than magnetic resonance imaging (MRI), being able to detect abnormalities in HIV-infected patients when imaging is normal.

KW - HIV

KW - Magnetic resonance spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=0029959304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029959304&partnerID=8YFLogxK

M3 - Article

C2 - 8898669

AN - SCOPUS:0029959304

VL - 13

SP - 247

EP - 253

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 3

ER -